OneSource Specialty Pharma partners with German firm to manufacture biosimilars for global markets

The partnership combines Formycon’s biosimilar development capabilities with OneSource’s end-to-end biologics manufacturing platform to support Formycon’s global biosimilar pipeline.

Leave a Reply

Your email address will not be published. Required fields are marked *